Delivery Order SPE2DB20D3505-SPE2DB23FT8H7
- Not listed
- This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,526.43 firm fixed-price contract is for the delivery of DEPAKOTE DR 125 MG SPRINKLE CP 100S, a medication used for the treatment of various conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop...
- This federal contract award is for a delivery order (SPE2DB23FP8J4) issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,253.85 firm fixed-price contract is for the supply of DEPAKOTE DR 125 MG SPRINKLE CP 100S, a medication used to treat various medical conditions. The contract has an ultimate completion date of September 25, 2023. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award, with ID SPE2DB20D1004 and SPE2DB22FG0Q5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,579.75 firm fixed-price delivery order is for the supply of 4558134727 - DEPAKOTE DR 125 MG SPRINKLE CP 100S, with a completion date of August 18, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider registered in SAM.gov through June 2025. The company holds an...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $15,757.85 firm fixed-price delivery order is for the supply of DEPAKOTE DR 125 MG SPRINKLE CP 100S, a pharmaceutical product. The contract has a completion date of July 26, 2022 and was awarded on July 25, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,894.44 firm-fixed-price delivery order is for the supply of 4567118119 DEPAKOTE ER 250 MG TABLET 100S. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,207.01 firm fixed-price delivery order is for the supply of 4,568,106,903 units of the medication Depakote DR 125 mg sprinkle capsules. The contract has a performance period through May 2, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award is for the delivery of 4,559,180 units of the pharmaceutical product Depakote DR 125 mg sprinkle capsules. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $2,774.15 and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award, valued at $1,064.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Depakote DR 125 mg sprinkle capsules, a medication used for various neurological and psychiatric conditions. The contract has an ultimate completion date of August 10, 2022 and is a Firm Fixed Price (FFP) agreement. The award is not associated with...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,565,527,969 units of the prescription drug Depakote DR 125 mg Sprinkle Capsules, with a total ceiling value of $1,350.72. The contract is a Firm Fixed Price Delivery Order that runs through August 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds several...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.55, is a Firm Fixed Price Delivery Order for the supply of Depakote DR 125 mg sprinkle capsules. The contract has a performance period through March 13, 2025 and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FT8H7Delivery Order
This federal contract award, with ID SPE2DB20D3505|SPE2DB23FT8H7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,323.84 delivery order is for the supply of 4560222536 DEPAKOTE DR 125 MG SPRINKLE CP 100S, a pharmaceutical product. The award is not designated as a set-aside contract. It is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov).
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 3/10/23 |